2024 Prostate Cancer Patient Symposium
Health event in Tampa, FL by Moffitt Cancer Center on Saturday, April 6 2024
Health event in Tampa, FL by Moffitt Cancer Center on Saturday, April 6 2024
Michael Basin presents an analysis on FGFR alterations and the genomic landscape differences between upper and lower tract urothelial carcinoma. Utilizing data from the extensive…
These guidelines are designed to help clinicians incorporate the latest recommendations into their clinical practice.
APOBEC, genetic mutations that contribute to bladder cancer development, muscle-invasive bladder cancer (MIBC), APOBEC-type driver mutations, APOBEC3B expression after infection with BKPyV.
Google on Wednesday unveiled an AI tool capable of predicting the structure and interaction of a vast universe of biomolecules.
Younger workers did gain significant benefit from the peer-to-peer program
Sam Chang engages with Arlene Siefker-Radtke to explore the transformative impact of erdafitinib in treating advanced and metastatic urothelial cancer. Dr. Siefker-Radtke illuminates the targeted…
Neal Shore and Mark Tyson discuss advances in non-muscle invasive bladder cancer treatments, particularly for BCG unresponsive patients. They delve into the approval and data…
Pars Fixa Urethral Strictures, pars fixa (PF), Phalloplasty, metoidioplasty, urethral strictures, Urethroplasty, buccal mucosal graft (BMG), ventral onlay buccal mucosal graft, stricturotomy.
There is a growing urgency for alternative solutions that support consumers where they are, and this is where the promise of digital health can be…
At the 2024 UCSF-UCLA PSMA Conference, Wolfgang Fendler emphasizes the transformative role of PSMA-PET imaging in managing castration-resistant prostate cancer (CRPC), showcasing its ability to…